阿斯利康不太可能在四月份之前获得EUA批准
据Warp Speed行动负责人Moncef Slaoui称，尽管英国昨天（12/30）批准，但阿斯利康和牛津大学的疫苗可能要到4月才能获得美国食品和药物管理局的紧急使用批准（EUA）。 有关疫苗功效以及老年人的患者安全性的问题引起了人们的关注，这些问题已推迟了该疫苗的EUA。 此外，Slaoui建议，由于Moderna以及Pfizer和BioNTech COVID-19，美国监管机构不会很好地接受该疫苗的功效率，即70％并远高于FDA对COVID-19疫苗的要求。 疫苗均超过90％。...
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com